tiprankstipranks
Valneva Seeks FDA Approval for Expanded Vaccine Use
PremiumCompany AnnouncementsValneva Seeks FDA Approval for Expanded Vaccine Use
2M ago
Valneva submits label extension application for chikungunya vaccine to FDA
Premium
The Fly
Valneva submits label extension application for chikungunya vaccine to FDA
2M ago
Valneva Engages Investors with Promising Vaccine Developments
Premium
Company Announcements
Valneva Engages Investors with Promising Vaccine Developments
2M ago
Valneva reports FDA Fast Track Designation for shigella vaccine candidate
PremiumThe FlyValneva reports FDA Fast Track Designation for shigella vaccine candidate
3M ago
Valneva price target lowered to $20 from $23 at H.C. Wainwright
Premium
The Fly
Valneva price target lowered to $20 from $23 at H.C. Wainwright
3M ago
Valneva Outlines Future Growth and Vaccine Pipeline
Premium
Company Announcements
Valneva Outlines Future Growth and Vaccine Pipeline
3M ago
H.C. Wainwright positive on second booster results for VLA15
PremiumThe FlyH.C. Wainwright positive on second booster results for VLA15
5M ago
Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
Premium
The Fly
Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
5M ago
Valneva Advances Lyme Disease Vaccine Candidate
Premium
Company Announcements
Valneva Advances Lyme Disease Vaccine Candidate
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100